Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

KMD Brands announces $25m ‘cost reset’
Retail

KMD Brands announces $25m ‘cost reset’

KMD Brands said it will take out $25 million in costs as part of a “Next Level” transformation plan aimed at restoring profitability.     In materials released alongside its 2025 Investor Day on Thursday, the outdoor retail group said the strategy is designed to "unlock the full...

Ikea NZ to open Dec 4
Retail

Ikea NZ to open Dec 4

Swedish retailer to open in time for Christmas.

No encore: Potentia exits Vista stake
Markets

No encore: Potentia exits Vista stake

Despite board snub, Australian investor is still keen on NZ software businesses.